Kim D. Pruitt
Kim D. Pruitt is a renowned bioinformatics scientist and the current head of the National Center for Biotechnology Information (NCBI). She has made significant contributions to the field of genomics and genetic research, particularly in the development of databases and tools for accessing and analyzing genomic data.
Early Life and Education[edit | edit source]
Pruitt was born and raised in the United States. She pursued her undergraduate studies in biology and later obtained her Ph.D. in molecular biology. Her doctoral research focused on the study of DNA sequencing and its applications in understanding genetic variations.
Career[edit | edit source]
Pruitt began her career as a research scientist at the NCBI, where she worked on the development of the GenBank database. This database is a crucial resource for researchers worldwide, providing access to a vast collection of publicly available nucleotide sequences and their associated annotations.
In 2013, Pruitt was appointed as the head of the NCBI, where she continues to oversee the development and maintenance of various databases and tools for genomic research. Under her leadership, the NCBI has launched several new initiatives, including the ClinVar database, which collects and annotates variants of clinical significance.
Contributions to Bioinformatics[edit | edit source]
Pruitt's work has significantly advanced the field of bioinformatics. Her contributions to the development of GenBank and ClinVar have facilitated the study of genetic variations and their implications for human health. She has also been instrumental in promoting the use of open data in genomics, advocating for the free and unrestricted access to genomic data for research purposes.
Awards and Recognition[edit | edit source]
In recognition of her contributions to bioinformatics, Pruitt has received several awards and honors. She is a fellow of the American Association for the Advancement of Science (AAAS) and has been recognized by the International Society for Computational Biology (ISCB) for her leadership in the field.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD